GuidelineClinical pharmacology and therapeutics2025

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Michael T Eadon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.